InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,004.54
(
-1.32%
)
US TECH 100
16,735.20
(
-1.91%
)
Dow Jones
37,892.80
(
-1.48%
)
Brent Oil
86.71
(
-0.59%
)
Bitcoin
63,356.09
(
-1.44%
)
Post# of 251590
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

jaybird249

Send PM Follow Ignore
Followers 82
Posts 2822
Boards Moderated 0
Alias Born 05/05/2006

jaybird249

Re: None

Tuesday, 10/04/2011 11:48:50 PM

Tuesday, October 04, 2011 11:48:50 PM

Post# of 251590
PATH could be a mini TSPT
I loaded up on TSPT lows 3's.

I have also been loading on PATH, which has a very effective Migraine drug. There are lots of similarities.

Both have low float with lots of cash and traded near $10 earlier in the year.
Both have very effective treatments for a large market medical need.

Both had FDA rejections not because of effecacy, but safety issues.

PATH released a PR a few days ago that appears to address the safety issue. If the get approval for the NDA resubmission PATH could be $5 in a hurry.

http://finance.yahoo.com/news/NuPathe-Reports-Positive-Top-iw-125358272.html?x=0

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up